Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine

Despite solid evidence of the success of rotavirus vaccines in saving children from fatal gastroenteritis, more than 82 million infants worldwide still lack access to a rotavirus vaccine. The main barriers to global rotavirus vaccine coverage include cost, manufacturing capacity and suboptimal effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamidi, Ahd, Hoeksema, Femke, Velthof, Pim, Lemckert, Angelique, Gillissen, Gert, Luitjens, Alfred, Bines, Julie E., Pullagurla, Swathi R., Kumar, Prashant, Volkin, David B., Joshi, Sangeeta B., Havenga, Menzo, Bakker, Wilfried A.M., Yallop, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062787/
https://www.ncbi.nlm.nih.gov/pubmed/33744044
http://dx.doi.org/10.1016/j.vaccine.2021.03.033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062787/
https://www.ncbi.nlm.nih.gov/pubmed/33744044
http://dx.doi.org/10.1016/j.vaccine.2021.03.033

Ejemplares similares